medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2006, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2006; 4 (4)

Leishmaniasis. A review

Vera-Izaguirre DS, Vega-Memije E, Quintanilla-Cedillo MR, Arenas R

Language: Spanish
References: 22
Page: 252-260
PDF size: 390.54 Kb.


ABSTRACT

Background: Leishmaniasis constitutes a variety of human diseases ranging in severity from a spontaneously healing skin ulcer to an overwhelming visceral disease. Leishmaniasis results from an infection with the protozoan parasite Leishmania SPP. The organism is transmitted to humans by the bite of the sandfly. Humans are usually accidental hosts and a variety of rodents, small mammals, and dogs are included as natural hosts. Disease is geographically and ecologically widespread, occurring in tropical and subtropical regions on all continents except Australia.
Worldwide, two million new cases occur each year, and a 10th of the world’s population is at risk of infection. The disease is highly endemic throughout northern Africa, the Middle East, parts of Europe, and Central and South America, but epidemics are well recognised. The incidence of leishmaniasis is increasing, with many endemic areas reporting a 500% increase over the past seven years.


REFERENCES

  1. Arenas, R. Leishmaniasis. Atlas. Dermatología, diagnóstico y tratamiento 2005; 111: 456-459

  2. Roberts LH. Leishmaniasis [Clinical review: Science, medicine, and the future]. British Medical Journal 2000; 321 (7264): 801-804

  3. Flisser A, Pérez-Tamayo R. Leishmaniasis. Aprendizaje de la parasitología basada en problemas. 2006; 41: 394-409

  4. Jones Jennifer M, Vega-López F, Higgins E, Bowling J. Leishmaniasis in children- A case series. J Am Acad Dermatol 2004; 175: 45

  5. Melby P. Vaccination against cutaneous leishmaniasis. Am J Clin Dermatol 2002; 3 (8): 557-570

  6. Hepburn N. Management of cutaneous leishmaniasis. Curr Opin Infect Dis 2001; 14: 151-154

  7. MMWR. Cutaneous Leishmaniasis in US Military Personnel-Southwest / Central Asia, 2002-2003. Arch Dermatol 2004; 140: 135-136

  8. Burgess IF. Cutaneous parasites. (Review Article). Current Opinion in Infectious Diseases 1998; 11 (2): 107-111

  9. Antonovich D. Cutaneous Leishmaniasis: A Diagnostic Challenge. J Am Acad Dermatol 2004; 394: 103

  10. Beena KR. Identification of parasite antigen, correlation of parasite density and inflammation in skin lesions of post kala-azar dermal leishmaniasis. J Cutan Pathol 2003; 30: 616-620

  11. Berman J. Chemotherapy of leishmaniasis: recent advances in the treatment of visceral disease (Review Article). Current Opinion in Infectious Di sea - ses 1998; 11 (6): 707-710

  12. Calza L, Marinacci G, Manfredi R, Colangeli V et al. Disseminated cutaneous leishmaniasis after visceral disease in a patient with Aids. J Am Acad Dermatol 2004; 50: 461-465

  13. Loiseau PMB, Christian. Recent strategies for the chemotherapy of visceral leishmaniasis. (Review Article). Current Opinion in Infectious Diseases 1999; 12 (6): 559-564

  14. Lira R, Arguello C. Leishmania mexicana: binding of promastigotes to type I collagen. Exp Parasitol 1997; 85: 149-157

  15. Clive R, Davies PK, Simon L Croft, Shyam Sundar. Leishmaniasis: new approaches to disease control. BMJ 2003; 326: 377-382

  16. Jebbari HD, Robert B. Recent advances in leishmaniasis. (Review Article). Current Opinion in Infectious Diseases 1998; 11 (5): 535-539

  17. Elhassan AM, Khalil E, Fadl A, Elhassan MM. The pathology of cutaneous leishmaniasis in the Sudan: a comparison with that in other geographical areas. Ann Trop Med Parasitol 1996; 90: 485-490

  18. Beverley SM, McMahon-Pratt D. Evolution of the genus Leishmania as revealed by comparasion of nuclear DNA restriction fragment patterns. Proc Natl Acad Sci USA 1987; 84: 484-488

  19. Grimaldi Jr DJ, McMahon-Pratt D. Identification and distribution of New World Leishmania species characterized by serodeme analysis using monoclonal antibodies. Am J Trop Med Hyg 1987; 36: 270-287

  20. Kreutzer RD, Semko ME. Biochemical identities and differences among Leishmania species and subspecies. Am J Trop Med Hyg 1987; 36: 22-32

  21. Wirth DF, Barker R Jr, Dourado H, Suesebang L, Albuquerque B. Leishmaniasis and malaria: New tools for epidemiologic analysis. Science 1986; 234: 975-979

  22. Desjeux P. Human leishmaniasis: epidemiology and public health aspects. World Health Stat Q 1992; 45: 267-275




2020     |     www.medigraphic.com